| dc.creator | Iliopoulou M., Skouras V., Psaroudaki Z., Makarona M., Vogiatzakis E., Tsorlini E., Katsifa E., Spyratos D., Siopi D., Kotsiou O., Xitsas S., Martsoukou M., Sigala I., Kalomenidis I. | en |
| dc.date.accessioned | 2023-01-31T08:28:27Z | |
| dc.date.available | 2023-01-31T08:28:27Z | |
| dc.date.issued | 2021 | |
| dc.identifier | 10.21037/JTD-20-2786 | |
| dc.identifier.issn | 20721439 | |
| dc.identifier.uri | http://hdl.handle.net/11615/74023 | |
| dc.description.abstract | Background: Community-acquired pleural infection (CAPI) is a growing health problem worldwide. Although most CAPI patients recover with antibiotics and pleural drainage, 20% require surgical intervention. The use of inappropriate antibiotics is a common cause of treatment failure. Awareness of the common causative bacteria along with their patterns of antibiotic resistance is critical in the selection of antibiotics in CAPI-patients. This study aimed to define CAPI bacteriology from the positive pleural fluid cultures, determine effective antibiotic regimens and investigate for associations between clinical features and risk for death or antibiotic-resistance, in order to advocate with more invasive techniques in the optimal timing. Methods: We examined 158 patients with culture positive, CAPI collected both retrospectively (2012-2013) and prospectively (2014-2018). Culture-positive, CAPI patients hospitalized in six tertiary hospitals in Greece were prospectively recruited (N=113). Bacteriological data from retrospectively detected patients were also used (N=45). Logistic regression analysis was performed to identify clinical features related to mortality, presence of certain bacteria and antibiotic resistance. Results: Streptococci, especially the non-pneumococcal ones, were the most common bacteria among the isolates, which were mostly sensitive to commonly used antibiotic combinations. RAPID score (i.e., clinical score for the stratification of mortality risk in patients with pleural infection; parameters: renal, age, purulence, infection source, and dietary factors), diabetes and CRP were independent predictors of mortality while several patient co-morbidities (e.g., diabetes, malignancy, chronic renal failure, etc.) were related to the presence of certain bacteria or antibiotic resistance. Conclusions: The dominance of streptococci among pleural fluid isolates from culture-positive, CAPI patients was demonstrated. Common antibiotic regimens were found highly effective in CAPI treatment. The predictive strength of RAPID score for CAPI mortality was confirmed while additional risk factors for mortality and antibiotic resistance were detected. © 2021 Journal of Thoracic Disease. All rights reserved. | en |
| dc.language.iso | en | en |
| dc.source | Journal of Thoracic Disease | en |
| dc.source.uri | https://www.scopus.com/inward/record.uri?eid=2-s2.0-85102706655&doi=10.21037%2fJTD-20-2786&partnerID=40&md5=9982e71ec30cb28c2cb8df1ce30f71fa | |
| dc.subject | aminopenicillin | en |
| dc.subject | antibiotic agent | en |
| dc.subject | C reactive protein | en |
| dc.subject | ceftriaxone | en |
| dc.subject | clindamycin | en |
| dc.subject | deoxyribonuclease | en |
| dc.subject | linezolid | en |
| dc.subject | meropenem | en |
| dc.subject | penicillin G | en |
| dc.subject | piperacillin plus tazobactam | en |
| dc.subject | quinoline derived antiinfective agent | en |
| dc.subject | tissue plasminogen activator | en |
| dc.subject | adult | en |
| dc.subject | anaerobic bacterium | en |
| dc.subject | antibiotic resistance | en |
| dc.subject | antibiotic sensitivity | en |
| dc.subject | Article | en |
| dc.subject | bacteriology | en |
| dc.subject | bacterium isolate | en |
| dc.subject | blood cell count | en |
| dc.subject | cerebrovascular disease | en |
| dc.subject | chronic kidney failure | en |
| dc.subject | clinical feature | en |
| dc.subject | community acquired infection | en |
| dc.subject | coughing | en |
| dc.subject | diabetes mellitus | en |
| dc.subject | disease assessment | en |
| dc.subject | enterococcal infection | en |
| dc.subject | Enterococcus | en |
| dc.subject | female | en |
| dc.subject | fever | en |
| dc.subject | fibrinolytic therapy | en |
| dc.subject | fungus | en |
| dc.subject | Gram negative bacterium | en |
| dc.subject | Gram positive bacterium | en |
| dc.subject | Gram positive cocci | en |
| dc.subject | Greece | en |
| dc.subject | hospital patient | en |
| dc.subject | human | en |
| dc.subject | Klebsiella | en |
| dc.subject | leukocyte count | en |
| dc.subject | logistic regression analysis | en |
| dc.subject | major clinical study | en |
| dc.subject | male | en |
| dc.subject | mortality risk | en |
| dc.subject | multicenter study | en |
| dc.subject | multidrug resistance | en |
| dc.subject | observational study | en |
| dc.subject | pleura disease | en |
| dc.subject | pleura effusion | en |
| dc.subject | pleura fluid | en |
| dc.subject | prevalence | en |
| dc.subject | RAPID score | en |
| dc.subject | risk assessment | en |
| dc.subject | sepsis | en |
| dc.subject | Sphingomonas paucimobilis | en |
| dc.subject | Staphylococcus aureus | en |
| dc.subject | Streptococcus infection | en |
| dc.subject | Streptococcus milleri | en |
| dc.subject | Streptococcus pneumoniae | en |
| dc.subject | tertiary care center | en |
| dc.subject | thorax pain | en |
| dc.subject | thorax radiography | en |
| dc.subject | treatment failure | en |
| dc.subject | AME Publishing Company | en |
| dc.title | Bacteriology, antibiotic resistance and risk stratification of patients with culture-positive, community-acquired pleural infection | en |
| dc.type | journalArticle | en |